drugset
drugset / Trial / NCT06246461

The Therapeutic Effect of Different Doses of Capecitabine

NCT06246461 ↗

Completed 150 enrolled Jingjiang People's Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

To observe the clinical efficacy and adverse reactions of capecitabine in the treatment of advanced colon cancer. A total of 150 patients with advanced colon cancer were selected by convenience sampling and then were divided into the control group (n = 50), the medium-dose group (n = 50), and the low-dose group (n = 50) using a random number table.Different administration regimens of capecitabine were given, and the treatment course was appropriately extended. The therapeutic effect and incidence of adverse reactions were observed.

Timeline

Start
2022-01-01
Primary completion
2023-12-31
Completion
2024-01-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule 750 mg/m2 Oral
Subject Capecitabine Small molecule 1000 mg/m2 Oral
Subject Capecitabine Small molecule 1250 mg/m2 Oral

Indications

No indication recorded.